Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (261-270 of 675) with videos related to

Pageof 68
Sort By:
Lipids in Health and Disease|December 29, 2017
Dietary patterns, plasma vitamins and Trans fatty acids are associated with peripheral artery diseaseMohsen Mazidi, Nathan D Wong, Niki Katsiki, et al.
Current Pharmaceutical Design|January 29, 2008
Emerging indications for statins: a pluripotent family of agents with several potential applicationsKosmas I Paraskevas, Alexandros A Tzovaras, Despina D Briana, et al.
Angiology|January 13, 2017
Appropriate Patient Selection for Carotid Revascularization Procedures is Urgently NeededKosmas I Paraskevas, Frank J Veith, Dimitri P Mikhailidis, et al.
Angiology|March 6, 2008
Achieving vascular risk factor targets: a survey of a London general practiceAdam P Levine, Dimitri P Mikhailidis, Tessa Moross, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 22, 2006
Alcohol use, vascular disease, and lipid-lowering drugsGenovefa D Kolovou, Klelia D Salpea, Katherine K Anagnostopoulou, et al.
Current Vascular Pharmacology|July 4, 2017
Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?Niki Katsiki, Pablo Perez-Martinez, Panagiotis Anagnostis, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 28, 2009
Endothelial dysfunction in patients with noncomplicated and complicated hypertensionAleksander Goch, Maciej Banach, Dimitri P Mikhailidis, et al.
Current Medical Research and Opinion|August 19, 2007
Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statinIrene F Gazi, Stella S Daskalopoulou, Devaki R Nair, et al.
Current Pharmaceutical Design|November 1, 2006
Lipid lowering therapy in the elderly: is there a benefit?Kallirroi J Kalantzi, Haralampos J Milionis, Dimitri P Mikhailidis, et al.
The American Journal of the Medical Sciences|June 16, 2007
The prevalence of metabolic syndrome in various populationsGenovefa D Kolovou, Katherine K Anagnostopoulou, Klelia D Salpea, et al.
Pageof 68

Showing results (261-270 of 675) with videos related to

Sort By:
Pageof 68
Lipids in Health and Disease|December 29, 2017
Dietary patterns, plasma vitamins and Trans fatty acids are associated with peripheral artery diseaseMohsen Mazidi, Nathan D Wong, Niki Katsiki, et al.
Current Pharmaceutical Design|January 29, 2008
Emerging indications for statins: a pluripotent family of agents with several potential applicationsKosmas I Paraskevas, Alexandros A Tzovaras, Despina D Briana, et al.
Angiology|January 13, 2017
Appropriate Patient Selection for Carotid Revascularization Procedures is Urgently NeededKosmas I Paraskevas, Frank J Veith, Dimitri P Mikhailidis, et al.
Angiology|March 6, 2008
Achieving vascular risk factor targets: a survey of a London general practiceAdam P Levine, Dimitri P Mikhailidis, Tessa Moross, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 22, 2006
Alcohol use, vascular disease, and lipid-lowering drugsGenovefa D Kolovou, Klelia D Salpea, Katherine K Anagnostopoulou, et al.
Current Vascular Pharmacology|July 4, 2017
Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?Niki Katsiki, Pablo Perez-Martinez, Panagiotis Anagnostis, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 28, 2009
Endothelial dysfunction in patients with noncomplicated and complicated hypertensionAleksander Goch, Maciej Banach, Dimitri P Mikhailidis, et al.
Current Medical Research and Opinion|August 19, 2007
Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statinIrene F Gazi, Stella S Daskalopoulou, Devaki R Nair, et al.
Current Pharmaceutical Design|November 1, 2006
Lipid lowering therapy in the elderly: is there a benefit?Kallirroi J Kalantzi, Haralampos J Milionis, Dimitri P Mikhailidis, et al.
The American Journal of the Medical Sciences|June 16, 2007
The prevalence of metabolic syndrome in various populationsGenovefa D Kolovou, Katherine K Anagnostopoulou, Klelia D Salpea, et al.
Pageof 68